| Year |
Citation |
Score |
| 2024 |
Amontree M, Nelson M, Stefansson L, Pak D, Maguire-Zeiss K, Turner RS, Conant K. Resveratrol differentially affects MMP-9 release from neurons and glia; implications for therapeutic efficacy. Journal of Neurochemistry. PMID 38163875 DOI: 10.1111/jnc.16031 |
0.35 |
|
| 2020 |
Sánchez K, Maguire-Zeiss K. MMP13 Expression Is Increased Following Mutant α-Synuclein Exposure and Promotes Inflammatory Responses in Microglia. Frontiers in Neuroscience. 14: 585544. PMID 33343280 DOI: 10.3389/fnins.2020.585544 |
0.402 |
|
| 2019 |
Bozzelli PL, Yin T, Avdoshina V, Mocchetti I, Conant KE, Maguire-Zeiss KA. HIV-1 Tat promotes astrocytic release of CCL2 through MMP/PAR-1 signaling. Glia. PMID 31124192 DOI: 10.1002/Glia.23642 |
0.428 |
|
| 2017 |
Conant K, Daniele S, Bozzelli PL, Abdi T, Edwards A, Szklarczyk A, Olchefske I, Ottenheimer D, Maguire-Zeiss K. Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation. Journal of Neuroinflammation. 14: 56. PMID 28302163 DOI: 10.1186/S12974-017-0827-4 |
0.406 |
|
| 2016 |
Allen M, Ghosh S, Ahern GP, Villapol S, Maguire-Zeiss KA, Conant K. Protease induced plasticity: matrix metalloproteinase-1 promotes neurostructural changes through activation of protease activated receptor 1. Scientific Reports. 6: 35497. PMID 27762280 DOI: 10.1038/Srep35497 |
0.362 |
|
| 2013 |
Béraud D, Hathaway HA, Trecki J, Chasovskikh S, Johnson DA, Johnson JA, Federoff HJ, Shimoji M, Mhyre TR, Maguire-Zeiss KA. Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 94-117. PMID 23054368 DOI: 10.1007/S11481-012-9401-0 |
0.331 |
|
| 2012 |
Conant K, Lim ST, Randall B, Maguire-Zeiss KA. Matrix metalloproteinase dependent cleavage of cell adhesion molecules in the pathogenesis of CNS dysfunction with HIV and methamphetamine. Current Hiv Research. 10: 384-91. PMID 22591362 DOI: 10.2174/157016212802138733 |
0.38 |
|
| 2011 |
Feng LR, Maguire-Zeiss KA. Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance. Neurotoxicity Research. 20: 387-401. PMID 21735318 DOI: 10.1007/s12640-011-9255-x |
0.398 |
|
| 2011 |
Conant K, Lonskaya I, Szklarczyk A, Krall C, Steiner J, Maguire-Zeiss K, Lim ST. Methamphetamine-associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule-5. Journal of Neurochemistry. 118: 521-32. PMID 21166806 DOI: 10.1111/J.1471-4159.2010.07153.X |
0.379 |
|
| 2010 |
Khandelwal PJ, Dumanis SB, Feng LR, Maguire-Zeiss K, Rebeck G, Lashuel HA, Moussa CE. Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model. Molecular Neurodegeneration. 5: 47. PMID 21050448 DOI: 10.1186/1750-1326-5-47 |
0.418 |
|
| 2010 |
Feng LR, Federoff HJ, Vicini S, Maguire-Zeiss KA. Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability. The European Journal of Neuroscience. 32: 10-7. PMID 20550572 DOI: 10.1111/J.1460-9568.2010.07266.X |
0.33 |
|
| 2010 |
Maguire-Zeiss KA, Federoff HJ. Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 1019-25. PMID 20549523 DOI: 10.1007/S00702-010-0431-6 |
0.323 |
|
| 2010 |
Feng LR, Maguire-Zeiss KA. Gene therapy in Parkinson's disease: rationale and current status. Cns Drugs. 24: 177-92. PMID 20155994 DOI: 10.2165/11533740-000000000-00000 |
0.364 |
|
| 2009 |
Federoff HJ, Brown M, Dakshanamurthy S, Maguire-Zeiss K. Potential of Nurr1 interactions to disclose new Parkinson's therapeutics Future Neurology. 4: 161-165. DOI: 10.2217/14796708.4.2.161 |
0.335 |
|
| 2008 |
Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ. Synuclein activates microglia in a model of Parkinson's disease. Neurobiology of Aging. 29: 1690-701. PMID 17537546 DOI: 10.1016/J.Neurobiolaging.2007.04.006 |
0.33 |
|
| 2005 |
Maguire-Zeiss KA, Short DW, Federoff HJ. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? Brain Research. Molecular Brain Research. 134: 18-23. PMID 15790526 DOI: 10.1016/J.Molbrainres.2004.09.014 |
0.302 |
|
| Show low-probability matches. |